In addition, catecholamine-induced β2-AR activation mediates desensitization of gastric cancer cells to EGFR antibodies (transtuzumab) by upregulating Mucin 4 (MUC4) expression [58]. This evidence concerns the gene MUC4 and gastric cancer.